Recent Finacing
Recent Raise
Chondrial Therapeutics is a small biotech developing CTI-1601, a university-licensed therapy for Friedreich’s ataxia, conducting IND-enabling studies and preparing Phase 1 trials from its Philadelphia-area lab.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Chondrial Therapeutics.
